Grasp the latest information from Olin and understand the new trends in the industry.
On March 26, 2026, Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”, Stock Code: 688319) and Westlake University officially signed a cooperation agreement. Following multiple on-site inspections and in-
Recently, the China National Intellectual Property Administration issued the Notice on Determining the Demonstration Creation Objects for the Construction of a National Intellectual Property Powerhouse (2025-2027). Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”) was successfully selected as a “National Intellectual Property Demonstration Enterprise Creation Object” by virtue of its systematic layout and outstanding achievements in the comprehensive management of in
On December 11, 2025, Mr. Matthew Fosbery, Deputy Commercial Consul of Australia in Chengdu and Trade & Investment Commissioner of Austrade, and Ms. Wang Ming, Commercial Officer of Austrade, visited Chengdu Olymvax Biopharmaceuticals Inc. (hereinafter referred to as “Olymvax”, stock code: 688319) for inspection and exchanges, and had in-
Mr. Liu Jian, Deputy Director General of the Department of International Cooperation of China National Intellectual Property Administration, visited OLYMVAX for investigation and guidance...
On December 15, 2022, the OLYMVAX Research Institute was completed and started business in Chengdu Tianfu International Bio-town, serving as a powerful engine for vaccine research and development! A group of leaders attended the inauguration ceremony of OLYMVAX Research Institute to witness this important development milestone of OLYMVAX, including Fan Shaowen...
On October 13, Shanghai Stock Exchange and China Securities Index Co., Ltd. officially announced the release arrangement of the SSE STAR Growth Index (referred to as STAR Growth). As one of two selected enterprises in Sichuan,...
Recently, the China National Intellectual Property Administration publicized the evaluation results of the 2022 National Enterprises with Advantage in IPRs and Demonstration Enterprises,...
Vaccines have played an irreplaceable role from vaccinia vaccination against smallpox in the 18th century in England to the national prevention and control of pandemic diseases typified by COVID-19 in the 21st century.